Index of /Coronavirus_(Wuhan_2019-nCov)/Covid-19_Vaccines/Vaccines_papers + studies

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]ACS_Risk_Biomarkers_Significantly_Increase_After_mRNA_COVID-19_Vaccine - The_Cardiology_Advisor.pdf2021-11-21 12:39 161K 
[ ]A_highly_immunogenic_and_effective_measles_virus-based_Th1-biased_COVID-19_vaccine_(Horner_et_al)_PNAS_Microbiology_December_22_2020_Vol.117_no.51_pp_32657–32666.pdf2025-03-29 14:45 1.4M 
[ ]Abstract 10712_ mRNA_COVID_Vaccines_Dramatically_Increase_Endothelial_Inflammatory_Markers_and_ACS_Risk_as_Measured_by_the_PULS_Cardiac_Test_ a_Warning _ Circulation.pdf2021-11-21 12:43 88K 
[ ]Antibody-dependent_enhancement_(ADE)_and_SARS-CoV-2_vaccines_and_therapies_(Wen_Shi_Lee_et_al)_Nature_Microbiology.pdf2021-04-08 19:46 1.6M 
[ ]Antibody_evolution_after_SARS-CoV-2_mRNA_Vaccination_Cho_et_al_July_29_2021.pdf2021-07-30 13:54 5.8M 
[ ]Are_COVID-19_Vaccines_in_Pregnancy_as_Safe_and_Effective_as_the_U.S_Government_Medical_Organizations_and_Pharmaceutical_Industry_Claim_(Thorp_et_al)_preprints202406.2062.v1_June_2024.pdf2025-01-24 11:19 2.7M 
[ ]BioNTech_RNA-Based_COVID-19_Injections_Contain_Large_Amounts_Of_Residual_DNA_Including_An_SV40_Promoter-Enhancer_Sequence_(Kammerer_et_al)_World_Society_for_Ethical_Science_v5.2019-2024.pdf2024-12-04 15:55 841K 
[ ]COVID-19_A_Risk_Factor_for_Cerebral_Thrombotic_Syndromes_(Rogers_et_al)_IJIRMS_Vol.9_Iss.11_November_2024.pdf2024-11-09 20:14 2.3M 
[ ]COVID-19_RNA_Based_Vaccines_and_the_Risk_of_Prion_Disease_J._Bart_Classen_Jan_2021_Journal_of_Microbiology_+_Infectious_Diseases.pdf2021-02-14 13:53 301K 
[ ]COVID-19_Vaccine_mRNA_Biodistribution_Maternal_and_Fetal_Exposure_Risks_(Zhong_et_al)_American_Journal_of_Reproductive_Immunology_October_2024.pdf2025-01-24 11:25 245K 
[ ]COVID-19_Vaccines_-_A_Risk_Factor_for_Cerebral_Thrombotic_Syndromes_(Rogers_et_al)_IJIRMS_Vol.9_Iss.11_November_2024.pdf2024-11-08 12:55 351K 
[ ]COVID-19_Vaccines_The_Impact_on_Pregnancy_Outcomes_and_Menstrual_Function_(Thorp_et_al)_Journal_of_American_Physicians_and_Surgeons_Vol.28_No.1_Spring_2023.pdf2025-04-05 09:24 2.7M 
[ ]COVID_vaccination_and_post-infection_cancer_signals_-_Evaluating_patterns_and_potential_biological_mechanisms_(Charlotte_Kuperwasser_and_Wafik_S_El-Deiry)_Oncotarget_2026_Vol.17_pp_1-29.pdf2026-01-04 13:51 5.2M 
[ ]Circulating_SARS-CoV-2_Vaccine_Antigen_Detected_in_the_Plasma_of_mRNA-1273_Vaccine_Recipients_(Ogata et al) May_2021.pdf2021-05-29 16:17 614K 
[ ]Comparing_SARS-CoV-2_natural_immunity_to_vaccine-induced_immunity_reinfections_versus_breakthrough_infections_(Gazit_et_al)_August_2021-2021.08.24.21262415v1.full.pdf2021-12-11 18:37 152K 
[ ]Comprehensive_investigations_revealed_consistent_pathophysiological_alterations_after_vaccination_with_COVID-19_vaccines_(Jiping_Liu_et_al)_Cell_Discovery_2021-10-26.pdf2021-10-31 09:16 3.6M 
[ ]Covid-19_Breakthrough_Infections_in_Vaccinated_Health_Care_Workers_Moriah_Bergwerk_et_al_(NEJM_July_2021).pdf2021-08-10 15:53 262K 
[ ]Detection_of_spike_protein_in_term_placentas_of_COVID-19_vaccinated_and-or_SARS-CoV-2_infected_women_Bartmann_et-al_(PLOS_One_March_5_2026)-pone.0344185.pdf2026-04-09 12:29 1.7M 
[ ]Differences_in_Vaccine_and_SARS-CoV-2_Replication_Derived_mRNA-Implications_for_Cell_Biology_and_Future_Disease_11-24-21.Submit-0SF-2_(McKernan_+_McCullough).pdf2021-12-11 12:55 3.6M 
[ ]Durability_of_Transgene_Expression_and_Vector_Integration_-_Recombinant_SV40-Derived_Gene_Therapy_Vectors_(Strayer_et_al)_Molecular_Therapy_Vol.6_No.2_August_2002.pdf2025-01-25 22:41 1.4M 
[ ]Early_effectiveness_of_COVID-19_vaccination_with_BNT162b2_mRNA_vaccine_and_ChAdOx1_adenovirus_vector_vaccine_on_symptomatic_disease_hospitalisations_+_mortality_in_older_adults_in_England.pdf2021-03-05 14:38 400K 
[ ]Effectiveness_of_Covid-19_vaccination_against_risk_of_symptomatic_infection_hospitalization_and_death_up_to_9_months_a_Swedish_total_population_cohort_study_(Nordstrom_et_al)-SSRN-id3949410.pdf2021-11-25 10:58 962K 
[ ]Efficacy_of_the_NVX-CoV2373_Covid-19_Vaccine_Against_the_B.1.1.7_Variant_(Heath_et_al)_May_2021-2021.05.13.21256639v1.full.pdf2021-06-01 16:41 1.9M 
[ ]Efficacy_of_the_mRNA-1273_SARS-CoV-2_Vaccine_at_Completion_of_Blinded_Phase_(NEJM_October_2021)_Hana_et_al_nejmoa2113017.pdf2021-12-06 15:30 855K 
[ ]Evaluating_the_number_of_unvaccinated_people_needed_to_exclude_to_prevent_SARS-CoV-2_transmissions_(Prosser_et_al)_December_2021-2021.12.08.21267162v1.full.pdf2021-12-12 15:42 871K 
[ ]Exploring_COVID-19_vaccine_adverse_events_among_pregnant_women_-_a_cross-sectional_study_2022_(Amer_et_al)_2024 Vol. 12_1–25_(10.1177_25151355241285594).pdf2025-01-24 11:21 965K 
[ ]Immune_imprinting_breadth_of_variant_recognition_and_germinal_center_response_in_human_SARS-CoV-2_infection_and_vaccination-(Rotgen_et_al-Cell_magazine)_March_2022_issue.pdf2022-02-16 13:28 32M 
[ ]Immunological_and_Antigenic_Signatures_Associated_with_Chronic_Illnesses_after_1_COVID-19_Vaccination _(Bhattacharjee_et_al)_medRxiv_preprint_February_2025.pdf2025-02-20 10:22 1.5M 
[ ]Impact_of_mRNA_and_Inactivated_COVID-19_Vaccines_on_Ovarian_Reserve_Karaman_et-al_(MDPI_Vaccines_2025, 13, 345)_vaccines-13-00345.pdf2026-04-09 12:29 6.2M 
[ ]Informed_consent_disclosure_to_vaccine_trial_subjects_of_risk_of_COVID-19_vaccines_worsening_clinical_disease_Wiley_ijcp.13795.pdf2021-03-05 17:20 290K 
[ ]Judicial_Precedents_and_Vaccine_Mandates_Aaron_Kheriaty_MD_2021-10-13_Human_Flourishing.pdf2021-10-13 09:45 610K 
[ ]Lancet_Letter_Demolishes_Vaccination_Igor_Chudov_Nov_2021.pdf2021-12-01 10:41 206K 
[ ]Mechanisms_of_SARS-CoV-2_Evolution_Revealing_Vaccine-Resistant_Mutations_in_Europe_and_America_(Wang_et_al)_PubMed_Dec_2021.pdf2021-12-08 10:54 81K 
[ ]Moderna_mRNA_Vaccine_study_done_pub_2017_showing_LNP_mRNA_Vaccines_do_NOT_stay_at_the_site_of_injection_(Bahl_et_al).pdf2021-08-16 14:03 8.4M 
[ ]Mucosal_immune_responses_to_SARS-CoV-2_infection_and_COVID-19_vaccination_(Paul_et_al)_Elsevier_Vaccine_56_(2025)_127175.pdf2025-05-08 13:02 4.2M 
[ ]Next_generation_self-replicating_RNA_vectors_for_vaccines_and_immunotherapies_(Aliahmad_et_al)_Nature_CGT_February_2022-s41417-022-00435-8.pdf2025-04-18 19:31 821K 
[ ]Phase_I_II_study_of_COVID-19_RNA_vaccine_BNT162b1_in_adults_(Mulligan_et-al)_Aug_2020.pdf2021-02-04 20:22 2.3M 
[ ]Placental_Histopathological_Changes_and_the_Level_of_Anti-Spike_Antibody_After_Covid-19_Vaccination_During_Pregnancy_(Heidary_et_al)_Journal_of_Reproduction_&_Infertility_Vol.25_Issue_no.3_May_2024_JRI-25-231.pdf2025-01-24 11:21 342K 
[ ]Pseudouridine guides germline small RNA transport and epigenetic inheritances_Nature_September_2024_41594-024-01392-6.pdf2024-12-30 18:47 18M 
[ ]Psychiatric adverse events following COVID-19 vaccination - a population-based cohort study in Seoul, South Korea (Hong Jin Kim et al) Molecular Psychiatry June 2024.pdf2026-01-24 11:10 1.3M 
[ ]REACT-2_Round_8_increasing_prevalence_of_SARS-CoV-2_antibodies_demonstrate_impact_of_the_second_wave_and_of_vaccine_roll-out_in_England_(Ward_et_al)_Feb_2021.pdf2021-03-18 17:22 2.0M 
[ ]Rates_of_successful_conceptions_according_to_COVID-19_vaccination_status_Data_from_Czech_Republic_Manniche_et_al_(Intl_Jnl_of_Risk_+_Safety_in_Med)_2025_Vol._36(4)_302–306).pdf2026-04-09 12:20 684K 
[ ]Review_of_COVID-19_Vaccines_and_the_Risk_of_Chronic_Adverse_Events_Including_Neurological_Degeneration_Classen_March_24_2021.pdf2021-08-31 14:36 327K 
[ ]Review_of_Calls_for_Market_Removal_of_COVID-19_Vaccines_Intensify_Risks_Far_Outweigh_Theoretical_Benefits_(Hulscher_et_al)_IPAK_Science_Public_Health_Policy_ and_the_Law_Volume_v6.2019-2025_Jan_2025.pdf2025-01-29 06:56 1.6M 
[ ]Risk_of_Myopericarditis_following_COVID-19_mRNA_vaccination_in_a_Large_Integrated_Health_System_A_Comparison_of_Completeness_and_Timeliness_of_Two_Methods_(Sharif_et_al)_December_2021-2021.12.21.21268209v1.full.pdf2022-01-10 14:38 789K 
[ ]SARS-CoV-2_Prion-Like_Domains_in_Spike_Proteins_Enable_Higher_Affinity_to_ACE2_(Tetz + Tetz April_2020)_Human_Microbiology_Institute-preprints202003.0422.v1.pdf2021-04-07 20:58 506K 
[ ]SARS-CoV-2_Spike_Protein_Elicits_Cell_Signaling_in_Human_Host Cells_Implications_for_Possible_Consequences_of_COVID-19_Vaccines_(Suzuki_et_al_MDPI)_January_2021.pdf2021-06-03 16:20 691K 
[ ]SARS-CoV-2_mRNA_vaccine_design_enabled_by_prototype_pathogen_preparedness_(Corbett_et_al)_Aug_2020_s41586-020-2622-0.pdf2020-11-16 12:16 9.2M 
[ ]SARS-CoV-2_spike_protein_S1_induces_fibrin(ogen)_resistant_to_fibrinolysis_Implications_for_microclot_formation_in_COVID-19_Grobbelaar_et_al)_March_2021.pdf2021-06-04 13:27 2.3M 
[ ]Scanning_+_Transmission_Electron_Microscopy_Reveals_Graphene_Oxide_in_CoV-19_Vaccines_(Robert_O_Young)_Aug_20_2021.pdf2021-09-03 16:10 35M 
[ ]Study_on_electromagnetism_of_vaccinated_persons_in_Luxembourg_(Mamer)_June_06_2021.pdf2021-06-28 13:29 225K 
[ ]Study_to_Describe_the_Safety_Tolerability_Immunogenicity_+_Efficacy_of_RNA_Vaccine_Candidates_Against_COVID-19_in_Healthy_Individuals_ClinicalTrials.gov.pdf2021-02-04 20:21 337K 
[ ]Temporal Analysis of Vaccine Adverse Effects for Causation Inference_preprints202312.1385.v2.pdf2024-12-30 18:11 1.5M 
[ ]The_epidemiological_relevance_of_the_COVID-19-vaccinated_population_is_increasing_The_Lancet_(Gunter_Kampf_2021-11-03).pdf2021-12-01 10:39 359K 
[ ]US_COVID-19_Vaccines_Proven_to_Cause_More_Harm_than_Good_Based_on_Pivotal_Clinical_Trial_Data_(J.Bart_Classen)_August_25_2021.pdf2021-08-31 12:58 378K 
[ ]Vaccine_Induced_Covid-19_Mimicry_Syndrome_Spike_protein_variants_that_may_cause_thromboembolic_events_Kowarz_et_al_(May_2021).pdf2021-05-29 11:47 776K 
[ ]View_of_Worse_Than_the_Disease_ Reviewing_Some_Possible_Unintended_Consequences_of_the_mRNA_Vaccines_Against_COVID-19_(Seneff_+_Nigh).pdf2021-05-15 11:27 13M 
Apache/2.4.29 (Ubuntu) Server at avalonlibrary.net Port 443